U.S. markets closed

CLASS ACTION UPDATE for PRA, WORX and CTMX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / June 24, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

PRA Shareholders Click Here: https://www.zlk.com/pslra-1/proassurance-corporation-loss-form?prid=7540&wire=1
WORX Shareholders Click Here: https://www.zlk.com/pslra-1/scworx-corp-loss-submission-form?prid=7540&wire=1
CTMX Shareholders Click Here: https://www.zlk.com/pslra-1/cytomx-therapeutics-inc-loss-submission-form?prid=7540&wire=1

* ADDITIONAL INFORMATION BELOW *

ProAssurance Corporation (PRA)

PRA Lawsuit on behalf of: investors who purchased April 26, 2019 - May 7, 2020
Lead Plaintiff Deadline: August 17, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/proassurance-corporation-loss-form?prid=7540&wire=1

According to the filed complaint, during the class period, ProAssurance Corporation made materially false and/or misleading statements and/or failed to disclose that: (i) ProAssurance lacked adequate underwriting process and risk management controls necessary to set appropriate loss reserves in its Specialty P&C segment; (ii) ProAssurance failed to properly assess a large national healthcare account that experienced losses far exceeding the assumptions made when the account was underwritten; and (iii) as a result, ProAssurance was subject to materially heightened risk of financial loss and reserve charges.

SCWorx Corp. (WORX)

WORX Lawsuit on behalf of: investors who purchased April 13, 2020 - April 17, 2020
Lead Plaintiff Deadline: June 29, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/scworx-corp-loss-submission-form?prid=7540&wire=1

According to the filed complaint, during the class period, SCWorx Corp. made materially false and/or misleading statements and/or failed to disclose that: (1) SCWorx's supplier for COVID-19 tests had previously misrepresented its operations; (2) SCWorx's buyer was a small company that was unlikely to adequately support the purported volume of orders for COVID-19 tests; (3) as a result, the Company's purchase order for COVID-19 tests had been overstated or entirely fabricated; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

CytomX Therapeutics, Inc. (CTMX)

CTMX Lawsuit on behalf of: investors who purchased May 17, 2018 - May 13, 2020
Lead Plaintiff Deadline: July 20, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/cytomx-therapeutics-inc-loss-submission-form?prid=7540&wire=1

According to the filed complaint, during the class period, CytomX Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) CytomX had downplayed issues with CX-072's efficacy observed in the PROCLAIM-CX-072 clinical program; (ii) CytomX had similarly downplayed issues with CX-2009's efficacy and safety observed in the PROCLAIM-CX-2009 clinical program; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/595161/CLASS-ACTION-UPDATE-for-PRA-WORX-and-CTMX-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders